89 related articles for article (PubMed ID: 12840525)
1. Applications of inhibitors for protein kinase C and their isoforms.
Shen GX; Way KJ; Jacobs JR; King GL
Methods Mol Biol; 2003; 233():397-422. PubMed ID: 12840525
[No Abstract] [Full Text] [Related]
2. Protein kinase C intervention: the state of play.
Roffey J; Rosse C; Linch M; Hibbert A; McDonald NQ; Parker PJ
Curr Opin Cell Biol; 2009 Apr; 21(2):268-79. PubMed ID: 19233632
[TBL] [Abstract][Full Text] [Related]
3. Genetic manipulation of protein kinase C in vivo.
Toker A
Methods Mol Biol; 2003; 233():475-89. PubMed ID: 12840530
[No Abstract] [Full Text] [Related]
4. Phorbol esters as probes for the study of protein kinase C function.
Kazanietz MG; Lorenzo PS
Methods Mol Biol; 2003; 233():423-39. PubMed ID: 12840526
[No Abstract] [Full Text] [Related]
5. Antisense oligonucleotide inhibitors of isozymes of protein kinase C: in vitro and in vivo activity, and clinical development as anti-cancer therapeutics.
McGraw K; McKay R; Miraglia L; Boggs RT; Pribble JP; Muller M; Geiger T; Fabbro D; Dean NM
Anticancer Drug Des; 1997 Jul; 12(5):315-26. PubMed ID: 9236849
[No Abstract] [Full Text] [Related]
6. Protease-activated receptor-2 stimulates intestinal epithelial chloride transport through activation of PLC and selective PKC isoforms.
van der Merwe JQ; Moreau F; MacNaughton WK
Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1258-66. PubMed ID: 19359428
[TBL] [Abstract][Full Text] [Related]
7. Yeast as a host to screen for modulators and regulatory regions of mammalian protein kinase C isoforms.
Parissenti AM; Riedel H
Methods Mol Biol; 2003; 233():491-516. PubMed ID: 12840531
[No Abstract] [Full Text] [Related]
8. C-5 Substituted heteroaryl 3-pyridinecarbonitriles as PKCtheta inhibitors: Part I.
Subrath J; Wang D; Wu B; Niu C; Boschelli DH; Lee J; Yang X; Brennan A; Chaudhary D
Bioorg Med Chem Lett; 2009 Sep; 19(18):5423-5. PubMed ID: 19682896
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase C isozymes in stroke.
Chou WH; Messing RO
Trends Cardiovasc Med; 2005 Feb; 15(2):47-51. PubMed ID: 15885569
[TBL] [Abstract][Full Text] [Related]
10. Irreversible inactivation of protein kinase C isozymes by thiol-reactive peptide substrate analogs.
O'Brian CA; Ward NE; Chu F; Stewart JR
Methods Mol Biol; 2003; 233():441-9. PubMed ID: 12840527
[No Abstract] [Full Text] [Related]
11. Competitive inhibitors and allosteric activators of protein kinase C isoenzymes: a personal account and progress report on transferring academic discoveries to the clinic.
Budas GR; Koyanagi T; Churchill EN; Mochly-Rosen D
Biochem Soc Trans; 2007 Nov; 35(Pt 5):1021-6. PubMed ID: 17956268
[TBL] [Abstract][Full Text] [Related]
12. Activation of glucose transport during simulated ischemia in H9c2 cardiac myoblasts is mediated by protein kinase C isoforms.
Agnetti G; Maraldi T; Fiorentini D; Giordano E; Prata C; Hakim G; Muscari C; Guarnieri C; Caldarera CM
Life Sci; 2005 Dec; 78(3):264-70. PubMed ID: 16111715
[TBL] [Abstract][Full Text] [Related]
13. Development of selective bisubstrate-based inhibitors against protein kinase C (PKC) isozymes by using dynamic peptide microarrays.
Poot AJ; van Ameijde J; Slijper M; van den Berg A; Hilhorst R; Ruijtenbeek R; Rijkers DT; Liskamp RM
Chembiochem; 2009 Aug; 10(12):2042-51. PubMed ID: 19618415
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological probes for protein kinase C: an introduction.
Kazanietz MG
Methods Mol Biol; 2003; 233():389-95. PubMed ID: 12840524
[No Abstract] [Full Text] [Related]
15. Relevance of atypical protein kinase C isotypes to the drug discovery process.
Jenny M; Wrulich OA; Schwaiger W; Ueberall F
Chembiochem; 2005 Mar; 6(3):491-9. PubMed ID: 15712318
[No Abstract] [Full Text] [Related]
16. Protein kinase C and its substrates.
Liu JP
Mol Cell Endocrinol; 1996 Jan; 116(1):1-29. PubMed ID: 8822261
[No Abstract] [Full Text] [Related]
17. Bacterial expression and purification of C1 and C2 domains of protein kinase C isoforms.
Cho W; Digman M; Ananthanarayanan B; Stahelin RV
Methods Mol Biol; 2003; 233():291-8. PubMed ID: 12840516
[No Abstract] [Full Text] [Related]
18. Specific modulation of apoptosis and Bcl-xL phosphorylation in yeast by distinct mammalian protein kinase C isoforms.
Saraiva L; Silva RD; Pereira G; Gonçalves J; Côrte-Real M
J Cell Sci; 2006 Aug; 119(Pt 15):3171-81. PubMed ID: 16835272
[TBL] [Abstract][Full Text] [Related]
19. Survival role of protein kinase C (PKC) in chronic lymphocytic leukemia and determination of isoform expression pattern and genes altered by PKC inhibition.
Alkan S; Huang Q; Ergin M; Denning MF; Nand S; Maududi T; Paner GP; Ozpuyan F; Izban KF
Am J Hematol; 2005 Jun; 79(2):97-106. PubMed ID: 15929099
[TBL] [Abstract][Full Text] [Related]
20. Isozyme-specific inhibitors and activators of protein kinase C.
Schechtman D; Mochly-Rosen D
Methods Enzymol; 2002; 345():470-89. PubMed ID: 11665630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
